Genotype and allele frequencies of polymorphic UGT1A9 in the Polish population

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 38, Issue 3, 2013, Pages 217-221

  Zakerska, Oliwia ^a,d   Skrzypczak Zielinska, Marzena ^b   Mikstacki, Adam ^c   Tamowicz, Barbara ^c   Malengowska, Bianka ^d   Szalata, Marlena ^b,d   Slomski, Ryszard ^b,d  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b INSTITUTE OF HUMAN GENETICS   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Allele frequencies; Polish population; Polymorphic drug metabolism; UDP glucuronosyltransferase; UGT1A9

Indexed keywords

GENOMIC DNA; GLUCURONOSYLTRANSFERASE 1A9;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ETHNIC GROUP; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MUTATION RATE; PHARMACOGENETICS; PILOT STUDY; POLISH; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PYROSEQUENCING;

GENE FREQUENCY; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; POLAND; POLYMORPHISM, GENETIC;

EID: 84890315787     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-012-0110-0     Document Type: Article

References (23)

1. Bernard O, Guillemette C (2004) The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Dispos 32:775-778
2. Girard H, Court MH, Bernard O, Fortier LC, Villeneuve L, Hao Q, Greenblatt DJ, von Moltke LL, Perussed L, Guillemette C (2004) Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics 14(8):501-515
3. Girard H, Villeneuve L, Court MH, Fortier LC, Caron P, Hao Q, von Moltke LL, Greenblatt DJ, Guillemette C (2006) The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver. Drug Metab Dispos 34(7):1220-1228
4. Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC (2001) Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11(4):357-368
5. Jinno H, Saeki M, Saito Y, Tanaka-Kagawa T, Hanioka N, Sai K, Kaniwa N, Ando M, Shirao K, Minami H, Ohtsu A, Yoshida T, Saijo N, Ozawa S, Sawada J (2003) Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients. J Pharmacol Exp Ther 306(2):688-693
6. King CD, Rios GR, Green MD, Tephly TR (2000) UDP- glucuronosyltransferases. Curr Drug Metab 1(2):143-161 Review
7. Korprasertthaworn P, Udomuksorn W, Yoovathaworn K (2009) Three novel single nucleotide polymorphisms of UGT1A9 in a Thai population. Drug Metab Pharmacokinet 24(5):482-485
8. Lévesque E, Delage R, Benoit-Biancamano MO, Caron P, Bernard O, Couture F, Guillemette C (2007) The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers. Clin Pharmacol Ther 81(3):392-400
9. Mehlotra RK, Bockarie MJ, Zimmerman PA (2007) Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations. Eur J Clin Pharmacol 63(1):1-8
10. Olson KC, Dellinger RW, Zhong Q, Sun D, Amin S, Spratt TE, Lazarus P (2009) Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene. Drug Metab Dispos 37(10):1999-2007
11. Paoluzzi L, Singh AS, Price DK, Danesi R, Mathijssen RH, Verweij J et al (2004) Influence of genetic variants in UGT1A1 and UGT1A9 on the in vitro glucuronidation of SN-38. J Clin Pharmacol 44:854-860
12. Parke TJ, Stevens JE, Rice AS, Greenaway CL, Bray RJ, Smith PJ et al (1992) Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 305(6854):613-616
13. Piepoli A, Gentile A, Valvano MR, Barana D, Oliani C, Cotugno R, Quitadamo M, Andriulli A, Perri F (2006) Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. World J Gastroenterol 12(39):6343-6348
14. Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS (1992) A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 267(5):3257-3261
15. Saeki M, Saito Y, Jinno H, Sai K, Komamura K, Ueno K, Kamakura S, Kitakaze M, Shirao K, Minami H, Ohtsu A, Yoshida T, Saijo N, Ozawa S, Sawada J (2003) Three novel single nucleotide polymorphisms in UGT1A9. Drug Metab Pharmacokinet 18(2):146-149
16. Saeki M, Saito Y, Jinno H, Sai K, Ozawa S et al (2006) Haplotype structures of the UGT1A gene complex in a Japanese population. Pharmacogenomics J 6(1):63-75
17. Strassburg CP, Manns MP, Tukey RH (1998) Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 273(15):8719-8726
18. Takahashi H, Maruo Y, Mori A, Iwai M, Sato H, Takeuchi Y (2008) Effect of D256 N and Y483D on propofol glucuronidation by human uridine 5′-diphosphate glucuronosyltransferase (UGT1A9). Basic Clin Pharmacol Toxicol 103(2):131-136
19. Thibaudeau J, Lépine J, Tojcic J, Duguay Y, Pelletier G, Plante M, Brisson J, Têtu B, Jacob S, Perusse L, Bélanger A, Guillemette C (2006) Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Res 66(1):125-133
20. Villeneuve L, Girard H, Fortier LC, Gagné JF, Guillemette C (2003) Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J Pharmacol Exp Ther 307(1):117-128
21. Watanabe Y, Nakajima M, Yokoi T (2002) Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10. Drug Metab Dispos 30(12):1462-1469
22. Wolf AR, Potter F (2004) Propofol infusion in children: when does an anesthetic tool become an intensive care liability? Paediatr Anaesth 14:435-438
23. Yamanaka H, Nakajima M, Katoh M, Hara Y, Tachibana O, Yamashita J, McLeod HL, Yokoi T (2004) A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. Pharmacogenetics 14(5):329-332